X4 Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Aug 23 | BuyUS$29,875 | Michael Wyzga | Individual | 25,000 | US$1.20 | |
10 Aug 23 | SellUS$137,859 | Murray Stewart | Individual | 130,056 | US$1.06 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 16,209 | 0.00965% |
Individual Insiders | 8,155,448 | 4.86% |
VC/PE Firms | 31,902,577 | 19% |
General Public | 39,358,541 | 23.4% |
Institutions | 88,505,006 | 52.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
16,915,784 | US$9.8m | 13.7% | 1.06% | |||
14,986,793 | US$8.7m | 0% | 0.57% | |||
8,735,867 | US$5.1m | 3.78% | no data | |||
8,374,789 | US$4.9m | 0% | 6.45% | |||
7,827,727 | US$4.5m | -2.26% | no data | |||
7,133,515 | US$4.1m | 0% | 0.06% | |||
6,367,131 | US$3.7m | 0% | no data | |||
6,198,684 | US$3.6m | 0% | 28.25% | |||
4,579,926 | US$2.7m | 0% | 0.25% | |||
4,276,315 | US$2.5m | 0% | no data | |||
3,588,427 | US$2.1m | 0% | 0.79% | |||
3,545,454 | US$2.1m | 0% | 0.04% | |||
3,473,683 | US$2.0m | 0% | 0.26% | |||
3,074,372 | US$1.8m | 0.03% | no data | |||
2,945,424 | US$1.7m | 5.1% | no data | |||
2,756,296 | US$1.6m | 0% | 0.09% | |||
2,523,555 | US$1.5m | 3.94% | no data | |||
2,435,426 | US$1.4m | 0% | no data | |||
2,413,000 | US$1.4m | 0% | 0.06% | |||
1,405,474 | US$815.2k | 251% | no data | |||
1,335,521 | US$774.6k | -23.4% | 0.07% | |||
1,054,488 | US$611.6k | -0.8% | no data | |||
1,032,746 | US$599.0k | 2,130% | no data | |||
915,000 | US$530.7k | 66.6% | no data | |||
805,359 | US$467.1k | 4.96% | 0.06% |